Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma Co N.V (NAMS) Shares Outstanding: 2022-2024

Historic Shares Outstanding for NewAmsterdam Pharma Co N.V (NAMS) over the last 3 years, with Dec 2024 value amounting to $108.1 million.

  • NewAmsterdam Pharma Co N.V's Shares Outstanding rose 22.79% to $113.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.2 million, marking a year-over-year increase of 22.79%. This contributed to the annual value of $108.1 million for FY2024, which is 31.04% up from last year.
  • Latest data reveals that NewAmsterdam Pharma Co N.V reported Shares Outstanding of $108.1 million as of FY2024, which was up 31.04% from $82.5 million recorded in FY2023.
  • Over the past 5 years, NewAmsterdam Pharma Co N.V's Shares Outstanding peaked at $108.1 million during FY2024, and registered a low of $81.6 million during FY2022.
  • For the 3-year period, NewAmsterdam Pharma Co N.V's Shares Outstanding averaged around $90.7 million, with its median value being $82.5 million (2023).
  • Data for NewAmsterdam Pharma Co N.V's Shares Outstanding shows a peak YoY spiked of 31.04% (in 2024) over the last 5 years.
  • NewAmsterdam Pharma Co N.V's Shares Outstanding (Yearly) stood at $81.6 million in 2022, then grew by 1.12% to $82.5 million in 2023, then surged by 31.04% to $108.1 million in 2024.